IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 411 - 420 of 523 for "Luxembourg" with applied filters

News & Analysis

2019 M&A Report: Luxembourg

01 March 2019 by Marcus Peter, GSK Stockmann (Luxembourg)

2018 has once again shown a growing trend in M&A transactions with a view to Luxembourg-based target entities as well as acquisitions outside of Luxembourg that were started using a Luxembourg structure. Luxembourg-based targets are typically not the centre of high-profile M&A targets.
News & Analysis

Arendt Case Review #4 - December 2018 - Arendt Litigation Group

21 January 2019 by Arendt & Medernach - Luxembourg

BRIEFING: Luxembourg, 21 January, 2019
News & Analysis

Back to 2018 – Forward to 2019

21 January 2019 by Arendt & Medernach - Luxembourg

BRIEFING: Luxembourg, 21 January, 2019
News & Analysis

GSK Stockmann in Luxembourg advises China Merchants Bank on its launch of their first European-based investment fund

04 January 2019 by GSK

GSK Stockmann’s Luxembourg office has advised China Merchants Bank (CMB) on its launch of CMB Evergreen SA, SICAV-SIF, a Luxembourg investment fund and being the first European-based investment fund of CMB.
News & Analysis

Elias Neocleous & Co LLC strengthens its presence in Western Europe

03 January 2019 by Elias Neocleous & Co - Cyprus

BRIEFING: Limassol, 3 January, 2019

News & Analysis

IFLR 2018 M&A Report: Luxembourg

19 December 2018 by GSK Stockmann

IFLR 2018 M&A Report: Luxembourg
News & Analysis

GSK Stockmann appoints its first International Partner and elects new co-Managing Partner

12 December 2018 by GSK

At the end of November 2018, GSK Stockmann’s Partners elected Andreas Heinzmann as International Partner and Dr. Uwe Jäger as new co-Managing Partner. These nominations underpin GSK’s commitment to internationaliza-tion and the consistent implementation of the modernization course the firm set out on.
News & Analysis

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2018

09 October 2018 by GSK

The Chinese Outbound Investment Guide 2018 has been published by International Financial Law Review (IFLR) and looks at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.
News & Analysis

GSK Stockmann advises Starwood Capital Group and Cells on Purchasing the Office Buildings Fifty Avon in Frankfurt

13 September 2018 by GSK

The joint venture of a Starwood Capital Group fund subsidiary and CELLS Property Investors bought the Fifty Avon office buildings in downtown Frank-furt in a share deal. GSK Stockmann provided the legal support for this trans-action. The parties agreed to keep the purchase price confidential.
News & Analysis

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2018

18 July 2018 by GSK

The Chinese Outbound Investment Guide 2018 has been published by International Financial Law Review (IFLR) and looks at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.
Load more